The global pulmonary function testing devices market revenue was around US$ 2.0 billion in 2022 and is estimated to reach US$ 3.5 billion by 2031, growing at a compound annual growth rate (CAGR) of ...

Conditions offering alternative explanations for lung cancer symptoms are associated with increased diagnostic intervals, according to a study published online Aug. 23 in the British Journal of Cancer ...

A new Mount Sinai study published in the Journal of the National Cancer Institute on September 10, 2024, has found that ...

COVID-19 has no impact on BMI trajectory or lung function in people with cystic fibrosis in the year following infection.

Simplified screening criteria were developed and found to identify more high-benefit people for lung cancer screening, especially among some minority groups.

Red blood cells are the most abundant cells in the body. It has long been known that when red blood cells break down or ...